Crossmark

Nanoemulsion-Based Delivery of Ricinoleic Acid Derived from Terminalia chebula: A Novel Strategy for Enhanced Bioavailability and Preclinical Constipation Management

Crossref DOI link: https://doi.org/10.1007/s12668-025-02257-y

Published Online: 2025-12-17

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dusi, Sharmila https://orcid.org/0000-0003-3971-8127
Saminathan, J. https://orcid.org/0000-0002-8301-0663
Sivakalai, S https://orcid.org/0000-0001-8558-0419
License Information

Text and Data Mining valid from 2025-12-17

Version of Record valid from 2025-12-17
More Information

Article History

Received: 29 July 2025

Accepted: 20 October 2025

First Online: 17 December 2025

Declarations

: The authors used Grammarly software solely for grammar and language editing. No AI-based writing tools were used in the preparation of this manuscript.

: The experimental protocol was approved by the Institutional Animal Ethics Committee (IAEC) of Delhi Pharmaceutical Sciences and Research University with reference number 215/GO/ReBi/2000/CPCSEA. All procedures were conducted in accordance with the CPCSEA guidelines on the protection of animals used for scientific purposes.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below